These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1093376)
1. Renal consequences of valvular heart disease. Porter GA; Bennett WM; Wilson JW Am J Cardiol; 1975 Jun; 35(6):886-97. PubMed ID: 1093376 [TBL] [Abstract][Full Text] [Related]
2. [Current acquisitions in diuresis and diuretic therapy]. Varese LA Minerva Pediatr; 1970 Oct; 22(41):1985-96. PubMed ID: 4924425 [No Abstract] [Full Text] [Related]
3. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure. Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739 [TBL] [Abstract][Full Text] [Related]
4. The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'. Verbrugge FH; Dupont M; Steels P; Grieten L; Swennen Q; Tang WH; Mullens W Eur J Heart Fail; 2014 Feb; 16(2):133-42. PubMed ID: 24464967 [TBL] [Abstract][Full Text] [Related]
5. Relationship of cardiorenal function to renin-aldosterone system in patients with valvular heart disease. Judson WE; Helmer OM Circulation; 1971 Aug; 44(2):245-53. PubMed ID: 5562560 [No Abstract] [Full Text] [Related]
6. The physiologic basis of sodium excretion and diuresis. Bricker NS; Klahr S Adv Intern Med; 1970; 16():17-41. PubMed ID: 4916359 [No Abstract] [Full Text] [Related]
7. Renal regulation of sodium excretion. Function in health and in edema-forming states. Klahr S; Slatopolsky E Arch Intern Med; 1973 Jun; 131(6):780-91. PubMed ID: 4576264 [No Abstract] [Full Text] [Related]
8. Disorders of water and electrolyte metabolism in liver disease. Summerskill WH; Barnardo DE; Baldus WP Am J Clin Nutr; 1970 Apr; 23(4):499-507. PubMed ID: 4914609 [No Abstract] [Full Text] [Related]
9. [Effect of diuretic measures in hydropic conditions. I. Planning, results in heart insufficiency]. Kaufmann W; Dürr F; Neuhaus GA; Praetorius F; Horbach L; Michaelis J Klin Wochenschr; 1969 Nov; 47(21):1130-42. PubMed ID: 5382002 [No Abstract] [Full Text] [Related]
15. [CLINICAL AND BIOCHEMICAL EVALUATION OF THE DIURETIC ACTION OF HYPOTHIAZIDE]. MERZON AK; KASIANOVA TN Klin Med (Mosk); 1964 Jan; 42():74-9. PubMed ID: 14150105 [No Abstract] [Full Text] [Related]
16. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE. CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808 [TBL] [Abstract][Full Text] [Related]
17. [Diuresis and diuretics]. Schmidt P Wien Klin Wochenschr; 1971 Jun; 83(25):456-9. PubMed ID: 5130897 [No Abstract] [Full Text] [Related]
18. [The 3d factor and associated problems]. Kato E; Yamauchi M; Ogawa M; Ishikawa J; Wada T Nihon Rinsho; 1969 Apr; 27(4):1132-40. PubMed ID: 4308816 [No Abstract] [Full Text] [Related]
19. EFFECTS OF ETHACRYNIC ACID (A NEW SALURETIC AGENT) ON RENAL DILUTING AND CONCENTRATING MECHANISMS: EVIDENCE FOR SITE OF ACTION IN THE LOOP OF HENLE. GOLDBERG M; MCCURDY DK; FOLTZ EL; BLUEMLE LW J Clin Invest; 1964 Feb; 43(2):201-16. PubMed ID: 14162529 [No Abstract] [Full Text] [Related]
20. [Use of diuretics in acute decompensated heart failure]. Akin I; Ince H; Rauchhaus M; Kische S; Rehders TC; Wenzel RR; Nienaber CA; Chatterjee T Praxis (Bern 1994); 2010 Jun; 99(12):705-14. PubMed ID: 20533230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]